A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator

A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator

CME/CE Broadcast Replay

A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator
RestartResume

Join us to learn about a new, nonhormonal method of contraception – the vaginal pH modulator, an FDA-approved nonhormonal, coitally dependent, user-controlled contraceptive that may help fill a gap in the availability of effective, patient-friendly birth control methods.

Available credits: 1.00

Time to complete: 60 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    The high rate of unintended pregnancy in the United States suggests an unmet need for effective, patient-friendly birth control methods. The FDA has recently approved a nonhormonal, coitally dependent, user-controlled contraceptive that may help fill this gap.

    In this activity, Drs. Eisenberg and Portman and Ms. Cason will discuss the role of vaginal pH modulators in contraception and how the current contraceptive trial design has contributed to the “creeping Pearl Index.”

    This was a live broadcast, the Q&A portion is no longer available.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    David L. Eisenberg, MD, MPH, FACOG
    Associate Professor
    Department of Obstetrics & Gynecology
    Washington University School of Medicine in St. Louis
    St. Louis, MO

    No relevant relationships reported

    Faculty:
    Patty Cason, RN, MS, FNP-C
    President
    Envision Sexual and Reproductive Health
    Los Angeles, CA

    Consulting Fees: Evofem Biosciences

    David J. Portman, MD
    Director Emeritus, Columbus Center for Women’s Health Research
    Adjunct Instructor, Obstetrics and Gynecology
    The Ohio State University College of Medicine
    Columbus, OH

    Advisory Board: Evofem Biosciences

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • David L. Eisenberg, MD, MPH, FACOG has reported no relevant relationships.
    • Barry A. Fiedel, PhD, has nothing to disclose.
    • Sue Grossman has nothing to disclose.
    • Judith Orvos, ELS, has nothing to disclose.
    • Robert Schneider, MSW has nothing to disclose. 
  • Learning Objectives

    After participating in this educational activity, learners should be better able to:

    • Explain the advantages and drawbacks of vaginal pH modulation contraception
    • Identify strategies to overcome common misperceptions regarding gel-based contraceptives that may detract from greater consideration of vaginal pH modulators
    • Discuss the scientific data underlying the increasing pregnancy rate demonstrated in contemporary clinical trials on contraception use
  • Target Audience

    This activity is designed to meet the educational needs of obstetrician-gynecologists, primary care physicians, nurse practitioners, certified nurse midwives, and physician assistants.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Evofem Biosciences.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

Facebook Comments

Register

We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free